Novartis chief Jimenez touts two top PhIII drug prospects
Novartis CEO Joe Jimenez has been busy giving interviews at Davos this week.
In a sit-down with Reuters the Basel-based exec noted that Trump …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
